WFN Press Releases

LONDON, July 17, 2026 -- The World Federation of Neurology (WFN) is pleased to announce Brain Health: Access for All as the theme for the 2026 World Brain Day. This global campaign aims to raise awareness of the importance of supporting brain health for all.

A comprehensive global roadmap of neurology that connects cutting-edge science with international healthcare policy. It tracks how brain health is managed across different economies (High vs. Low income) and serves as an essential guide for everyone from neurosurgeons to rehabilitation therapists.

The World Federation of Neurology (WFN) has appointed Dr. Paola Guraieb Chahin (Mexico) and Prof. Njideka Ulunma Okubadejo (Nigeria) as co-opted trustees.

Scheduled to take place on 28-29 October 2026, the WFN invites you to join the second World Federation of Neurology Digital Neurology Updates (WNU 2026)

The latest issue of World Neurology shares a comprehensive update from outgoing WFN President Prof. Wolfgang Grisold, reflecting on achievements and transitions across the organisation. At October's World Congress of Neurology (WCN) in Seoul, key leadership elections took place. 

Neurological conditions now affect more than 40% of the population—over 3 billion people, according to WHO’s Global Status Report on Neurology, released at the World Congress of Neurology (WCN) in Seoul. The report provides a comprehensive assessment of countries’ responses to neurological conditions and sets a baseline for monitoring progress under the Intersectoral global action plan on epilepsy and other neurological to improve brain health and reduce inequalities.

At the World Congress of Neurology, Prof. Sir John Hardy (UCL, London) highlighted how decades of genetic and molecular research are driving real progress in Alzheimer’s care, with advances in amyloid therapies, microglial biology, and biomarkers paving the way for more precise diagnosis and treatment.

At the World Congress of Neurology, Dr. Mikołaj Ogrodnik revealed that senescent cells also accumulate in the brain, driving neurodegeneration and cognitive decline. He highlighted emerging senolytic therapies and advances in targeting cellular aging, pointing to new possibilities for reversing age-related brain dysfunction.

At WCN, Prof. Charlotte Cordonnier urged neurologists to apply lessons from the ischemic stroke revolution to intracerebral hemorrhage (ICH) care and research. 2025

WFN is pleased to announce the results of its recent elections and warmly congratulates the newly elected leaders